neurodegenerative diseases Flashcards

1
Q

what is multiple sclerosis

A

inflammatory demyelinating disorder of the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

who usually presents with MS

A

females aged 20-50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

name some environmental factors associated with MS

A

viral infections e.g. EBV and vitamin D deficiency
smoking, latitude, diet and obesity in early life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathophysiology of MS

A

autoimmune disease that causes accumulation of plaques of demyelination in the white matter of the CNS
+ gliosis (scarring)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the most common first presentation of MS

A

optic neuritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

clinical presentation of optic neuritis

A

unilateral decrease in visual acuity, poor discrimination of colours, pain worse on eye movement, RAPD, central scotoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

fundoscopy of optic neuritis

A

pale, swollen disc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the 3 main patterns of disease in MS

A

relapsing remitting
secondary progressive
primary progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the most common pattern of disease in MS

A

relapsing remitting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

relapsing remitting MS

A

episodes or exacerbations of symptoms followed by periods of recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

secondary progressive MS

A

RR patients who have deteriorated and develop signs and symptoms between relapses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

primary progressive MS

A

steady progression and worsening of the disease from the onset (without remissions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how is a relapse of MS defined

A

onset of new symptoms or worsening of existing ones, lasting longer than 24hrs in the absence of infection or any other cause, after a stable period of at least a month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is a common complication of progressive MS and why

A

urinary frequency, urgency and incontinence
due to neurogenic detrusor overactivty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

clinical presentation of MS

A

paraesthesia, weakness, balance and mobility issues, fatigue, stiffness or spasms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

investigations for MS

A

CSF, MRI, bloods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CSF positive finding of MS

A

oligoclonal bands of IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MRI positive finding of MS

A

periventricular white matter lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

acute management of MS

A

glucocorticoids -> methylprednisolone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what does NMOSD stand for

A

neuromyelitis optica spectrum disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is NMOSD

A

inflammatory disease of the CNS that causes demyelination of the optic nerve and spinal cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

who usually presents with NMOSD

A

females, mid 30s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what can NMOSD often be mistaken for

A

multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how can we differentiate between MS and NMOSD

A

presence of aquaporin 4 antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

acute management of NMOSD

A

high dose steroids
(plasma exchange if needed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

chronic management of NMOSD

A

immunosuppression with steroid-sparing agents e.g. azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

who is more likely to develop MND

A

males (slightly!)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is the most common type of MND in adults

A

amyotrophic lateral sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what is the average survival time for a patient diagnosed with MND

A

3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is often associated with MND

A

frontotemporal dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

what is the main cause of death in patients with MND

A

weakness of respiratory muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

where is predominantly affected by MND

A

upper and lower motor neurones in the spinal cord, cranial nerve motor nuclei and cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

name some upper motor neuron signs

A

increased tone, hyper-reflexia, spastic gate, slowed movements

33
Q

name some lower motor neuron signs

A

muscle wasting, weakness, FASCICULATIONS, absent or reduced deep tendon reflexes

34
Q

what sign is associated with greater functional decline in MND

A

catabolism (hypermetabolism)

35
Q

what are the 4 main types of MND

A

spinal ALS
bulbar ALS
progressive muscular atrophy
primary lateral sclerosis

36
Q

what is split hand syndrome

A

preferential wasting of the thenar group (guttering) typically seen in ALS

37
Q

clinical presentation of spinal ALS

A

upper and lower motor neuron symptoms
e.g. spasticity, hyperreflexia, fasciculations, muscle
atrophy
usually in one limb

38
Q

who presents with bulbar ALS

A

men aged 60-80

39
Q

clinical presentation of bulbar ALS

A

early tongue and bulbar involvement
dysarthria, dysphagia, nasal regurgitation of fluids and choking

40
Q

clinical presentation of progressive muscular atrophy

A

ONLY LOWER MOTOR NEURONE FEATURES
weakness, muscle wasting, fasciculations

41
Q

clinical presentation of primary lateral sclerosis

A

ONLY UPPER MOTOR NEURONE FEATURES

42
Q

management of MND

A

supportive - MDT, pain relief, SLT involvement

43
Q

disease-modifying treatment in MND and what it does

A

riluzole - extends life expectancy by around 3 months

44
Q

what is Creutzfeldt-Jakob disease

A

a neurodegenerative disorder caused by prion proteins

45
Q

what are prions

A

misfolded proteins that induce normal proteins within the brain to misfold and aggregate, leading to neuronal loss

46
Q

genetics involved with Creutzfeldt-Jakob disease

A

PRNP gene mutation

47
Q

clinical presentation of Creutzfeldt-Jakob disease

A

rapidly progressive dementia, sleep disturbances, aphasia, apraxia, tremor, dystonia

48
Q

how do we confirm suspected Creutzfeldt-Jakob disease and when is investigation indicated

A

brain tissue biopsy
only indicated if there is a reversible condition suspected in the differential

49
Q

management of Creutzfeldt-Jakob disease

A

symptom control and palliative care

50
Q

what is the most common type of dementia

A

alzheimers

51
Q

what are the 4 main types of dementia

A

alzheimers
frontal lobe
lewy body
vascular

52
Q

name some secondary causes of dementia

A

brain infection, haematoma, normal pressure hydrocephalus, alcohol dementia, deficiencies

53
Q

clinical presentation of normal pressure hydrocephalus

A

triad of gait disturbance, dementia and urinary incontinence

54
Q

normal pressure hydrocephalus on imaging

A

ventricular enlargement

55
Q

what causes alzheimers disease

A

build up of amyloid protein deposits around brain cells and tau protein tangles within brain cells

56
Q

which type of dementia is liked to down syndrome

A

alzheimers

57
Q

what is vascular dementia

A

brain damage due to cerebrovascular disease

58
Q

how will vascular dementia present

A

usually later onset
presence of CVD + a clear temporal relationship between the onset of dementia and CVD

59
Q

what causes lewy body dementia

A

deposition of abnormal protein (a-synuclein) with neurons in the brainstem and neocortex

60
Q

what is the key area of the brain affected in lewy body dementia

A

substantia nigra

61
Q

inheritance seen in huntingtons

A

autosomal dominant

62
Q

name some secondary causes of dementia (with the mnemonic)

A

VITAMINS
vascular
infection
trauma
alcohol and drugs
metabolic (thyroid)
intracranial SOLs
nutritional deficiencies
SOLs

63
Q

which genetic phenomena does huntingtons demonstrate and what is it

A

anticipation - each generation develops a genetic disease at an earlier age

64
Q

clinical presentation of alzheimers

A

gradual onset, decline of short-term memory
autobiographical memory usually preserved
poor concentration, sleep and low mood

65
Q

clinical presentation of vascular dementia

A

step-wise deterioration, dysphasia, dyscalculia

66
Q

how does fronto-temporal dementia present

A

cognitive impairment, personality change, disinhibition

67
Q

which type of dementia is associated with constructional apraxia

A

fronto-temporal dementia

68
Q

how does dementia with lewy bodies present

A

visual hallucinations, fluctuating cognition, REM sleep behaviour disorder

69
Q

which cognitive assessment is used for suspected dementia

A

addenbrooks

70
Q

what can be a good tool for differentiating between alzheimers and vascular dementia

A

hachinski ischaemic score

71
Q

what is huntington’s disease

A

genetic disorder that causes progressive breakdown of nerve cells in the brain

72
Q

which area of the brain is most commonly degenerated in huntington’s disease

A

basal ganglia

73
Q

what is the classic triad patients with huntington’s present with

A

choreoathetosis, dementia and psychiatric abnormalities e.g. depression

74
Q

what is choreoathetosis

A

unpredictable, flowing and writhing movements

75
Q

management of the symptoms of huntington’s

A

chorea: tetrabenazine
depression: SSRIs

76
Q

standard imaging for suspected dementia

77
Q

management of severe alzheimers

78
Q

mechanism of action of memantine

A

NMDA receptor blocker

79
Q

name some other drugs used to manage alzheimers and their mechanism of action

A

cholinesterase inhibitors
donepezil, rivastigmine, galantamine

80
Q

management of vascular dementia

A

manage risk factors +/- cholinesterase inhibitors